Compare CSBR & XPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSBR | XPL |
|---|---|---|
| Founded | 1985 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.0M | 74.8M |
| IPO Year | 2015 | 2000 |
| Metric | CSBR | XPL |
|---|---|---|
| Price | $5.78 | $0.78 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.20 |
| AVG Volume (30 Days) | 5.7K | ★ 114.5K |
| Earning Date | 03-12-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 161.11 | 42.86 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,900,000.00 | N/A |
| Revenue This Year | $4.84 | N/A |
| Revenue Next Year | $11.51 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.50 | $0.54 |
| 52 Week High | $8.74 | $0.98 |
| Indicator | CSBR | XPL |
|---|---|---|
| Relative Strength Index (RSI) | 44.45 | 49.72 |
| Support Level | $5.66 | $0.69 |
| Resistance Level | $6.31 | $0.81 |
| Average True Range (ATR) | 0.39 | 0.03 |
| MACD | -0.05 | 0.00 |
| Stochastic Oscillator | 19.25 | 81.50 |
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
Solitario Resources Corp is an exploration company engaging in acquiring, exploring, and developing zinc properties and other precious metals in safe jurisdictions in North and South America. Its core mineral property assets are: the Florida Canyon zinc project in Peru, the Lik zinc project in Alaska, and the Golden Crest project in South Dakota. Additionally, Solitario holds an interest in the Chambara project in Peru and also has two early-stage projects, the Cat Creek project and the Bright Angel project in Colorado. The company is conducting mineral exploration on its Golden Crest project, the Cat Creek project, and the Bright Angel project on its own.